Hormone Replacement Therapy
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What Hormone Replacement Therapy Means
Hormone Replacement Therapy (HRT) is a treatment that provides hormones your body no longer makes enough of, especially during and after menopause. Menopause is a natural stage in a woman’s life when menstrual periods stop and hormone levels, mainly estrogen and progesterone, drop. This change can cause symptoms like hot flashes, night sweats, vaginal dryness, and discomfort during sex. HRT helps replace these hormones to relieve symptoms and may also protect against bone loss, which can lead to osteoporosis.
Why Hormone Replacement Therapy Matters in Cancer Care
In cancer care, hormone replacement therapy can be important for women who have hormone-related symptoms after treatment or surgery that affects hormone levels. However, because some cancers are sensitive to hormones, doctors carefully consider whether HRT is safe and appropriate. For example, women with certain types of breast or uterine cancer may be advised against HRT. Doctors may also test hormone receptor status of tumors to guide treatment decisions. Understanding HRT helps patients and caregivers discuss symptom relief and supportive care options safely.
What Patients Might See or Hear About HRT
You might hear HRT called menopausal hormone therapy or see it abbreviated as HRT in medical reports or treatment plans. It can be prescribed as pills, skin patches, gels, vaginal creams, or rings. The type and dose depend on your symptoms and whether you still have a uterus. Women with a uterus usually take estrogen combined with progestin to lower the risk of uterine cancer, while women without a uterus may take estrogen alone. Your healthcare provider will discuss the benefits and risks based on your health history.
Common Questions and Concerns About HRT
Many women wonder if HRT is safe and whether it will increase their risk of blood clots, heart disease, stroke, or cancer. It’s important to know that risks vary depending on the type of HRT, dose, how long it is used, and individual health factors. Your provider will recommend the lowest effective dose for the shortest time needed and will regularly check if you still need HRT. If you have a history of certain cancers, blood clots, liver disease, or unexplained vaginal bleeding, HRT may not be recommended.
How to Talk With Your Care Team About HRT
If you are considering or currently using HRT, ask your healthcare provider about the benefits and risks for your situation. Questions to ask include: What type of HRT is best for me? How long should I use it? What side effects should I watch for? How will we monitor my health while on HRT? Also, discuss any family history of cancer or blood clots, as this can affect your risk. Open communication helps you make informed decisions about managing menopausal symptoms safely.
Understanding HRT in Context
Seeing the term HRT in your medical records or cancer care plan does not automatically mean it is recommended or being used. It may be mentioned as part of symptom management, hormone testing, or treatment planning. It is not the same as antihormone therapy, which blocks hormones to treat some cancers. If you are unsure what HRT means in your care, ask your provider for a clear explanation tailored to your situation.
Important Safety Notes
This information is educational and does not replace medical advice. Hormone Replacement Therapy has benefits and risks that vary by individual. Only a healthcare provider familiar with your health history can decide if HRT is safe and appropriate for you. Never start or stop HRT without consulting your care team.
Next Steps for Patients and Caregivers
If you experience menopausal symptoms or have questions about hormone therapy, talk openly with your healthcare provider. They can help you understand your options, including HRT and alternatives, and guide you toward the safest and most effective care for your needs.
Sources
Public source information used for this glossary entry includes:
- National Cancer Institute (NIH): hormone replacement therapy
- National Cancer Institute (NIH): Menopausal Hormone Therapy and Cancer
- MedlinePlus (NIH/NLM): Hormone Replacement Therapy
- MedlinePlus (NIH/NLM): Vaginal Bleeding
- MedlinePlus (NIH/NLM): Primary Ovarian Insufficiency
- MedlinePlus (NIH/NLM): Pulmonary Embolism